These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 18177246)

  • 21. MTTP polymorphisms and hepatic steatosis in individuals chronically infected with hepatitis C virus.
    Prata TVG; Silva DSRD; Manchiero C; Dantas BP; Mazza CC; Nunes AKDS; Abdala E; Figueiredo GM; Tengan FM; Magri MC
    Arch Virol; 2019 Oct; 164(10):2559-2563. PubMed ID: 31321587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatocyte steatosis is an important predictor of response to interferon (IFN) monotherapy in Japanese patients infected with HCV genotype 2a: Virological features of IFN-resistant cases with hepatocyte steatosis.
    Akuta N; Suzuki F; Suzuki Y; Sezaki H; Hosaka T; Someya T; Kobayashi M; Saitoh S; Arase Y; Ikeda K; Kobayashi M; Kumada H
    J Med Virol; 2005 Apr; 75(4):550-8. PubMed ID: 15714492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.
    Petit JM; Benichou M; Duvillard L; Jooste V; Bour JB; Minello A; Verges B; Brun JM; Gambert P; Hillon P
    Am J Gastroenterol; 2003 May; 98(5):1150-4. PubMed ID: 12809841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic variation in the microsomal triglyceride transfer protein (-493G/T) is associated with hepatic steatosis in patients infected with hepatitis C virus.
    Magri MC; Prata TV; Manchiero C; Dantas BP; Mazza CC; Tengan FM
    BMC Infect Dis; 2017 Mar; 17(1):235. PubMed ID: 28356060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of association between microsomal triglyceride transfer protein gene polymorphism and liver steatosis in HCV-infected patients.
    Petit JM; Masson D; Minello A; Duvillard L; Galland F; Verges B; Gambert P; Hillon P
    Mol Genet Metab; 2006 Jun; 88(2):196-8. PubMed ID: 16458034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microsomal triglyceride transfer protein (MTP) -493G/T gene polymorphism contributes to fat liver accumulation in HCV genotype 3 infected patients.
    Zampino R; Ingrosso D; Durante-Mangoni E; Capasso R; Tripodi MF; Restivo L; Zappia V; Ruggiero G; Adinolfi LE
    J Viral Hepat; 2008 Oct; 15(10):740-6. PubMed ID: 18482281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of apolipoprotein C-IV is regulated by Ku antigen/peroxisome proliferator-activated receptor gamma complex and correlates with liver steatosis.
    Kim E; Li K; Lieu C; Tong S; Kawai S; Fukutomi T; Zhou Y; Wands J; Li J
    J Hepatol; 2008 Nov; 49(5):787-98. PubMed ID: 18809223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C virus core protein, lipid droplets and steatosis.
    Roingeard P; Hourioux C
    J Viral Hepat; 2008 Mar; 15(3):157-64. PubMed ID: 18086178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hepatitis-C infection and hepatic steatosis].
    Bosques-Padilla F
    Gac Med Mex; 2004; 140 Suppl 2():S73-6. PubMed ID: 15641475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatic iron, liver steatosis and viral genotypes in patients with chronic hepatitis C.
    Sebastiani G; Vario A; Ferrari A; Pistis R; Noventa F; Alberti A
    J Viral Hepat; 2006 Mar; 13(3):199-205. PubMed ID: 16475996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C.
    Miquilena-Colina ME; Lima-Cabello E; Sánchez-Campos S; García-Mediavilla MV; Fernández-Bermejo M; Lozano-Rodríguez T; Vargas-Castrillón J; Buqué X; Ochoa B; Aspichueta P; González-Gallego J; García-Monzón C
    Gut; 2011 Oct; 60(10):1394-402. PubMed ID: 21270117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity.
    Adinolfi LE; Gambardella M; Andreana A; Tripodi MF; Utili R; Ruggiero G
    Hepatology; 2001 Jun; 33(6):1358-64. PubMed ID: 11391523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.
    Zografos TA; Liaskos C; Rigopoulou EI; Togousidis E; Makaritsis K; Germenis A; Dalekos GN
    Am J Gastroenterol; 2008 Mar; 103(3):605-14. PubMed ID: 18190648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis C virus genotype 1: how genetic variability of the core protein affects the response to pegylated-interferon and ribavirin therapy.
    Alhamlan FS; Al-Ahdal MN; Khalaf NZ; Abdo AA; Sanai FM; Al-Ashgar HI; Elhefnawi M; Zaid A; Al-Qahtani AA
    J Med Virol; 2014 Feb; 86(2):224-34. PubMed ID: 24166351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between hepatic steatosis and MTP gene -493G/T polymorphism in the patients with HCV genotype 1 infection.
    Akgöllü E; Akkız H
    Infect Genet Evol; 2019 Jun; 70():101-106. PubMed ID: 30790698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different mechanisms of steatosis in hepatitis C virus genotypes 1 and 3 infections.
    Hézode C; Roudot-Thoraval F; Zafrani ES; Dhumeaux D; Pawlotsky JM
    J Viral Hepat; 2004 Sep; 11(5):455-8. PubMed ID: 15357652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipid Droplets Accumulation during Hepatitis C Virus Infection in Cell-Culture Varies among Genotype 1-3 Strains and Does Not Correlate with Virus Replication.
    Galli A; Ramirez S; Bukh J
    Viruses; 2021 Feb; 13(3):. PubMed ID: 33671086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C virus-induced steatosis: an overview.
    Negro F
    Dig Dis; 2010; 28(1):294-9. PubMed ID: 20460926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peroxisome proliferator-activated receptor-alpha and -gamma mRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infection.
    de Gottardi A; Pazienza V; Pugnale P; Bruttin F; Rubbia-Brandt L; Juge-Aubry CE; Meier CA; Hadengue A; Negro F
    Aliment Pharmacol Ther; 2006 Jan; 23(1):107-14. PubMed ID: 16393287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Steatosis, insulin resistance and fibrosis progression in chronic hepatitis C.
    Castera L
    Minerva Gastroenterol Dietol; 2006 Jun; 52(2):125-34. PubMed ID: 16557184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.